Our Technologies

Read about our available technologies and get in touch with our team

Filter

Sectors

Industries

Clear all filters

A wearable, non-invasive point of care tool to diagnose and monitor chronic obstructive pulmonary disorder (COPD) severity
A microfluidic device designed to accelerate the development of T-cell immunotherapies for cancer.
Innovative compressor inlet invention which increases compressor flow range with use of an inlet duct that pre-swirls inlet flow of turbocharger compressor.
A novel fast warm forming method which improves the manufacturing productivity of high-strength metal sheet parts
A novel cooling technique to improve the speed and sensitivity of RF measurements. The technique allows quantum measurements to be performed with room-temperature equipment, as well as more sensitive and quicker EPR and NMR measurements.
A novel method to fabricate porous metal mats with high porosity, variable/controllable thicknesses, high surface area and good mechanical strength
An entirely new MRI system that exploits the 55° magic angle to provide useful image contrast and novel information about the collagen microstructure in ligaments, tendons and menisci.
A method for fine-tuning gene expression in Yarrowia Lipoltica
Improved process for synthesizing ammonia under ambient conditions significantly reducing energy requirements and carbon emissions.
Methods to tune the porosity of boron nitride and shape porous boron nitride into densified ready-to-use macrostructures

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Licensing and IP performance 2019/20

Inventions disclosed

Imperial inventors submitted 250 invention disclosures to our IPC team during the year

Active licences

Imperial College London's licensing portfolio comprises 244 licences

Patents filed

Imperial filed 137 patents (including PCT applications) during the year

Patent portfolio

Imperial's patent portfolio reached 331 patents during the year

Upcoming Events

Imperial.tech.pitch events – learn more and sign up

Imperial.tech.pitch events – learn more and sign up

Event date - October 1, 2023

Learn about our programme of events and sign up to be alerted for future events Find out more

Latest News

Accelerated development of a potential treatment for cystic fibrosis

Accelerated development of a potential treatment for cystic fibrosis

The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more

Natural Killer – licensing a cell therapy

Natural Killer – licensing a cell therapy

Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more

Imperial partner Apollo receives £100m to boost medical research at leading unis

Imperial partner Apollo receives £100m to boost medical research at leading unis

Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more

Loading...